Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase (original) (raw)

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New Yor...

Sherryn Roth

Journal of the American College of Cardiology, 1998

View PDFchevron_right

Attenuated cross-linked fibrin degradation in patients treated with streptokinase and intravenous heparin

Dana Abendschein

Fibrinolysis, 1994

View PDFchevron_right

Antithrombin and Thrombolytic Effects of a New Antithrombin Agent: Angioscopic and Angiographic Comparison with Heparin or Batroxobin

Fumitaka Nakamura

Journal of Interventional Cardiology, 1994

View PDFchevron_right

Antithrombin-Heparin Covalent Complex: A Possible Alternative to Heparin for Arterial Thrombosis Prevention

Anthony Chan

Circulation, 2002

View PDFchevron_right

Thrombin Binds to Soluble Fibrin Degradation Products Where it Is Protected From Inhibition by Heparin-Antithrombin but Susceptible to Inactivation by Antithrombin-Independent Inhibitors

Jeffrey Weitz

Circulation, 1998

View PDFchevron_right

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial

Karen Pieper

Journal of the American College of Cardiology, 1998

View PDFchevron_right

Inhibition of Fibrin-Bound Thrombin by a Covalent Antithrombin-Heparin Complex

Anthony Chan

Journal of Biochemistry, 2002

View PDFchevron_right

Standard heparin but not LMW heparin induces a concomitant increase of t-PA and PAI-1 without modification of global fibrinolysis: study after 60 days treatment

Francis Lacombe

Thrombosis research, 1991

View PDFchevron_right

Heparin compromises streptokinase-induced arterial patency in rabbits

Janusz Rak

Thrombosis Research, 2005

View PDFchevron_right

Treatment of deep vein thrombosis with a very low molecular weight heparin (CY 222 - Choay): Thrombolysis and plasma fibrinolytic parameters

Marie-Christine Alessi

Fibrinolysis, 1988

View PDFchevron_right

Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system

Anthony Chan

Thrombosis and Haemostasis, 2013

View PDFchevron_right

Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin

Alberto Quispe

American Heart Journal, 2000

View PDFchevron_right

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

J. Maraganore

Journal of Clinical Investigation, 1990

View PDFchevron_right

Fibrin formation and platelet aggregation in patients with acute myocardial infarction: Effects of intravenous and subcutaneous low-dose heparin

A. Gallino

American Heart Journal, 1986

View PDFchevron_right

Direct thrombin inhibitors

Karen Kaplan

Expert Opinion on Pharmacotherapy, 2003

View PDFchevron_right

Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: A controlled cross-over randomized study

antonio fazi

American Heart Journal, 1988

View PDFchevron_right

Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial

Jerome Premmereur

The American Journal of Cardiology, 1998

View PDFchevron_right

ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN SUPPRESSES PROTHROMBIN ACTIVATION MORE EFFECTIVELY THAN UNFRACTIONATED HEPARIN IN PATIENTS TREATED FOR VENOUS THROMBOEMBOLISM

Alan Grosset

Thrombosis Research, 1997

View PDFchevron_right

HIT/HITT and alternative anticoagulation: current concepts

Egbert Pravinkumar

British Journal of Anaesthesia, 2003

View PDFchevron_right

In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris

Marcello Galvani

Arteriosclerosis, Thrombosis, and Vascular Biology, 2000

View PDFchevron_right

Another bleeding heart: perioperative heparin management revisited

Christopher Harle

Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2007

View PDFchevron_right

Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis

Sam Schulman

Thrombosis Research, 1985

View PDFchevron_right

Antithrombin-Heparin Covalent Complex

Jeffrey Weitz

Circulation, 2002

View PDFchevron_right

Clinical Biochemistry of Thrombin

Thomas Stief

2013

View PDFchevron_right

Repeated Doses of Oral and Subcutaneous Heparins Have Similar Antithrombotic Effects in a Rat Carotid Arterial Model of Thrombosis

Linda Hiebert

Journal of Cardiovascular Pharmacology and Therapeutics, 2011

View PDFchevron_right

Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial

Jose Julian Ariza Moreno

Acute Cardiac Care, 2011

View PDFchevron_right

Effect of Non-Heparin Thrombin Antagonists on Thrombin Generation, Platelet Function, and Clot Structure in Whole Blood

Pantep Angchaisuksiri

Cell Biochemistry and Biophysics, 2003

View PDFchevron_right

Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time

Coenraad Hemker

Journal of Thrombosis and Haemostasis, 2004

View PDFchevron_right

Influence of anticoagulant therapy in assessment of Fibrinolysis activity in post acute myocardial infarction patients

Asaad Mohammed Ahmed Babker ,Ph.D.,H(ASCPi),SH(ASCPi)

Scholars Academic Journal of Pharmacy (SAJP) , 2015

View PDFchevron_right

Thrombin Generation Assay and Viscoelastic Coagulation Monitors Demonstrate Differences in the Mode of Thrombin Inhibition Between Unfractionated Heparin and Bivalirudin

Taro Taketomi

Anesthesia & Analgesia, 2007

View PDFchevron_right

Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits

Jose Hermida

American Journal of Hematology, 1999

View PDFchevron_right